Why Is It So Hard to Tell People I’m on a GLP-1?
Important note: This article is for general education and support. It is not medical advice or mental health care. Your healthcare provider should guide questions about your medication and treatment plan. If shame, anxiety, secrecy, body image distress, or isolation feels significant or persistent, consider talking with a healthcare provider or mental health professional.
You started a GLP-1 for real reasons.
Maybe your doctor recommended it. Maybe you had tried other approaches before. Maybe your blood sugar, cholesterol, weight, mobility, or long-term health needed a different kind of support. Maybe it was simply time to take your health seriously in a new way.
And yet, somewhere between deciding to start and telling people in your life, a familiar feeling can show up.
Dread.
The mental rehearsal of what you will say if someone asks.
The decision to just not bring it up.
The quiet calculation of who feels safe to tell and who does not.
If you have felt this, you are not being dramatic. You are not being paranoid. You are not alone.
There is real research behind why GLP-1 disclosure can feel so loaded. And it has very little to do with you personally.
GLP-1 stigma is real
It would be easy to assume that judgment around GLP-1 medications is just internet noise. A few loud comments. A few celebrity headlines. A few people with opinions they did not need to share.
But recent research suggests the stigma is more measurable than that.
One study from researchers at Georgetown University and George Washington University found that women described as losing weight with GLP-1 medication were judged more harshly than women described as losing the same amount of weight through diet and exercise.
A separate study from researchers at Rice University found that people who lost weight using GLP-1 medications could face more negative social judgments than people who lost weight through diet and exercise. In some scenarios, GLP-1 medication use was judged more negatively than not losing weight at all.
The common thread is the “easy way out” narrative.
In other words, some people see medication-assisted weight loss as less earned, less disciplined, or less admirable, even though GLP-1 and GLP-1-related medications work through real biological systems involved in appetite, fullness, digestion, blood sugar, and metabolism.
That judgment is not based on the full reality of the GLP-1 journey. But it can still affect how people feel, what they share, and how safe they feel talking about their treatment.
Why the “easy way out” idea is so sticky
The “easy way out” narrative is powerful because it connects to an older belief: that body size is mostly a reflection of willpower.
For decades, weight has been treated as a moral scoreboard. People in larger bodies have often been judged as lazy, undisciplined, careless, or lacking self-control. Those beliefs are not only painful. They are also overly simplistic and scientifically incomplete.
GLP-1 medications challenge that old story.
They make it harder to pretend that appetite, fullness, cravings, food noise, blood sugar, digestion, and weight are only about discipline. They point to biology. They show that some people’s bodies may need medical support for systems that other people have been told to manage through willpower alone.
But instead of removing judgment, the medication can become a new target for it.
Before GLP-1s, a person might have been judged for their weight. After starting one, they may be judged for using medical support to address it.
That is part of why it can feel so unfair.
The same culture that tells people to “do something” about their weight may also criticize them for using a doctor-prescribed tool to do exactly that.
Why telling people can feel so vulnerable
Telling someone you are on a GLP-1 is not just sharing a medication name.
For many people, it can feel like opening the door to comments about their body, food, health, discipline, appearance, and private medical choices.
You may worry people will say:
- “Are you sure that’s safe?”
- “But you don’t need that.”
- “So you’re taking the easy way?”
- “What happens when you stop?”
- “I heard those drugs are dangerous.”
- “Why didn’t you just diet and exercise?”
Even if no one actually says those things, the possibility can be enough to make disclosure feel stressful.
That is because GLP-1 medications sit at the intersection of several sensitive topics: weight, health, food, body image, money, medical care, aging, metabolism, and social judgment.
It makes sense that you might not want to invite opinions into something that already feels personal.
Privacy is not the same as shame
You are allowed to keep your GLP-1 use private.
That does not mean you are ashamed.
It may mean you are protecting your peace. It may mean you are still processing the experience yourself. It may mean you do not want your body or your medication to become a group discussion. It may mean certain people in your life have not earned access to that information.
Privacy can be healthy.
You do not owe everyone the details of your medical care. You do not have to explain your prescription, defend your decision, or educate someone who is not asking in good faith.
There may be people you want to tell. There may be people you do not want to tell. There may be people you tell later, once you feel steadier.
All of those choices can be valid.
Being open is valid too
Some people feel relief when they talk about being on a GLP-1.
They may want to reduce stigma. They may want support. They may want to be honest with close friends or family. They may not want to pretend their body is changing for reasons that are not true.
That is valid too.
There is no single right way to handle disclosure. The right choice depends on your relationships, your safety, your comfort, your boundaries, and what kind of support you actually want.
The question is not, “Should everyone know?”
A better question is, “Who has earned the right to know this part of my life?”
What you can say if someone asks
You do not need a perfect script. But it can help to have a few options ready.
If you want to keep it private:
- “I’m focusing on my health with my doctor, but I’m keeping the details private.”
- “I appreciate you asking, but I’m not really discussing my medication.”
- “That’s something I’m working through with my healthcare provider.”
If you want to share a little:
- “My doctor prescribed a GLP-1, and it’s been part of my health plan.”
- “I’m using a doctor-prescribed medication to support my health.”
- “It’s been helpful, but it’s also been an adjustment.”
If someone is judgmental:
- “I’m not looking for opinions on my medical care.”
- “This was a decision I made with my healthcare provider.”
- “I know people have a lot of opinions about these medications. I’m comfortable with my decision.”
If someone is curious in a respectful way:
- “I’m happy to share what it’s been like for me, but everyone’s experience is different.”
- “It affects appetite and fullness, but it still takes a lot of day-to-day adjustment.”
- “It has helped, but it’s not magic. I still have to pay attention to food, hydration, side effects, and routines.”
You can share more, less, or nothing at all. You are allowed to decide in the moment.
The emotional part matters
GLP-1 conversations are often framed as medical, metabolic, or cosmetic. But for many people, the emotional side is just as real.
You may feel relief that food noise is quieter.
You may feel anger that people judge a tool that is helping you.
You may feel sadness that you did not get this kind of support earlier.
You may feel protective of your privacy.
You may feel proud and still not want attention.
You may feel frustrated that your body has become something other people feel allowed to comment on.
Those feelings do not mean you are doing anything wrong. They mean you are navigating a health decision inside a culture that has complicated, often unfair ideas about bodies and weight.
Where Glo fits in
Glo was built for the in-between moments of the GLP-1 journey.
Not just the medication questions. Not just the food questions. The people questions too.
The moment when you are rehearsing what to say to a family member.
The moment when someone’s comment stays with you longer than you expected.
The moment when you are trying to decide whether to keep your medication private.
The moment when you want to talk through what happened without managing someone else’s reaction.
Glo supports people using doctor-prescribed GLP-1 and GLP-1-related medications. Glo does not replace your healthcare provider, prescribe medication, recommend medication changes, diagnose mental health concerns, or provide therapy.
But Glo can give you a private place to organize your thoughts, track how you are feeling, understand general GLP-1 information in plain language, and feel less alone between appointments.
You do not owe anyone an explanation for a healthcare decision you made with your provider. But if you want space to think through what to say, or whether to say anything at all, Glo is there for that too.
The bottom line
If it feels hard to tell people you are on a GLP-1, there is a reason.
GLP-1 stigma is real. Research suggests people using these medications can face judgment tied to the belief that medication-assisted weight loss is a shortcut or less earned.
That belief is not the full truth.
GLP-1 medications work through real biological pathways. They can change appetite, fullness, digestion, and food-related signals. They do not erase the day-to-day work of caring for your body, managing side effects, eating enough, staying hydrated, moving when you can, and staying connected to your care team.
You are allowed to keep your medication private.
You are allowed to talk about it.
You are allowed to change your mind.
Your health decisions do not need to be publicly defended to be valid.
References
- Georgetown Lombardi Comprehensive Cancer Center. New Study Examines Stigma Toward Women Who Lose Weight Using GLP-1 Medications.
- Standen, E.C., et al. An experimental investigation of the stigmatization of individuals who lose weight using GLP-1 medications. International Journal of Obesity.
- Post, S.M., et al. The Effect of GLP-1 Receptor Agonist Use on Negative Evaluations of Women with Higher and Lower Body Weight. Stigma and Health.
- Heitmann, B.L., et al. The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes. Current Obesity Reports.
- Jensen, S.D., et al. Global observations on the social implications of GLP-1 receptor agonists. Humanities and Social Sciences Communications.
Category